The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
oleh: Imma Forzano, Pasquale Mone, Fahimeh Varzideh, Stanislovas S. Jankauskas, Urna Kansakar, Antonio De Luca, Gaetano Santulli, Gaetano Santulli
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2022-12-01 |
Deskripsi
Subjek
aldosterone; baxdrostat; blood pressure; BrigHTN; CIN-107; clinical trial